Left ventricular assist devices (LVADs) are associated with major vascular complications including stroke and gastrointestinal bleeding (GIB). These adverse vascular events may be the result of widespread vascular dysfunction resulting from pre-LVAD abnormalities or continuous flow during LVAD therapy. We hypothesized that pre-existing large artery atherosclerosis and/or abnormal blood flow as measured in carotid arteries using ultrasonography are associated with a post-implantation composite adverse outcome including stroke, GIB, or death. We retrospectively studied 141 adult HeartMate II patients who had carotid ultrasound duplex exams performed before and/or after LVAD surgery. Structural parameters examined included plaque burden and stenosis. Hemodynamic parameters included peak-systolic, end-diastolic, and mean velocity as well as pulsatility index. We examined the association of these measures with the composite outcome as well as individual subcomponents such as stroke. After adjusting for established risk factors, the composite adverse outcome was associated with pre-operative moderate-to-severe carotid plaque (OR 5.08, 95% CI 1.67–15.52) as well as pre-operative internal carotid artery stenosis (OR 9.02, 95% CI 1.06–76.56). In contrast, altered hemodynamics during LVAD support were not associated with the composite outcome. Our findings suggest that pre-existing atherosclerosis possibly in combination with LVAD hemodynamics may be an important contributor to adverse vascular events during mechanical support. This encourages greater awareness of carotid morphology pre-operatively and further study of the interaction between hemodynamics, pulsatility, and structural arterial disease during LVAD support.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Colombo PC, Mehra MR, Goldstein DJ, Estep JD, Salerno C, Jorde UP, et al. Comprehensive analysis of stroke in the long-term cohort of the MOMENTUM 3 Study. Circulation. 2019;139:155–68.
Krabatsch T, Netuka I, Schmitto JD, Zimpfer D, Garbade J, Rao V, et al. Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure—1 year results from the Ce mark trial. J Cardiothorac Surg. 2017;12:23.
Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC Jr, Colombo PC, et al. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2017;376:440–50.
Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015;34:1495–504.
Kirklin JK, Cantor R, Mohacsi P, Gummert J, De By T, Hannan MM, et al. First annual IMACS report: a global International Society for Heart and Lung Transplantation Registry for Mechanical Circulatory Support. J Heart Lung Transplant. 2016;35:407–12.
Draper KV, Huang RJ, Gerson LB. GI bleeding in patients with continuous-flow left ventricular assist devices: a systematic review and meta-analysis. Gastrointest Endosc. 2014;80:435-46e1.
Hasin T, Marmor Y, Kremers W, Topilsky Y, Severson CJ, Schirger JA, et al. Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol. 2013;61:153–63.
Cervini P, Park SJ, Shah DK, Penev IE, Lewis BD. Carotid Doppler ultrasound findings in patients with left ventricular assist devices. Ultrasound Q. 2010;26:255–61.
Kar B, Delgado RM 3rd, Radovancevic B, Myers TJ, Wadia Y, Letsou GV, et al. Vascular thrombosis during support with continuous flow ventricular assist devices: correlation with computerized flow simulations. Congest Heart Fail. 2005;11:182–7.
Kabbani LS, Munie S, Lin J, Velez M, Isseh I, Brooks S, et al. Flow Patterns in the Carotid Arteries of Patients with Left Ventricular Assist Devices. Ann Vasc Surg. 2017;39:182–8.
Coutsoumpos A, Patel S, Teruya TH, Chiriano J, Bianchi C, Abou-Zamzam AM Jr. Carotid duplex ultrasound changes associated with left ventricular assist devices. Ann Vasc Surg. 2014;28:1030e7-e11.
Castagna F, Stohr EJ, Pinsino A, Cockcroft JR, Willey J, Reshad Garan A, et al. The unique blood pressures and pulsatility of LVAD patients: current challenges and future opportunities. Curr Hypertens Rep. 2017;19:85.
Stöhr EJ, Castagna F, Pinsino A, Cockcroft JR, Yuzefpolskaya M, Garan AR, et al. Transmission of pulsatility into the brain of patients with continuous-flow left ventricular assist devices. THeart Lung Transplant. 2018;37:S284.
Shah P, Tantry US, Bliden KP, Gurbel PA. Bleeding and thrombosis associated with ventricular assist device therapy. J Heart Lung Transplant. 2017;36:1164–73.
Kim JH, Brophy DF, Shah KB. Continuous-flow left ventricular assist device-related gastrointestinal bleeding. Cardiol Clin. 2018;36:519–29.
Witman MA, Garten RS, Gifford JR, Groot HJ, Trinity JD, Stehlik J, et al. Further peripheral vascular dysfunction in heart failure patients with a continuous-flow left ventricular assist device: the role of pulsatility. JACC Heart Fail. 2015;3:703–11.
John R, Panch S, Hrabe J, Wei P, Solovey A, Joyce L, et al. Activation of endothelial and coagulation systems in left ventricular assist device recipients. Ann Thorac Surg. 2009;88:1171–9.
Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis–Society of Radiologists in Ultrasound Consensus Conference. Radiology. 2003;229:340–6.
Lee W. General principles of carotid Doppler ultrasonography. Ultrasonography. 2014;33:11–7.
Kirklin JK, Xie R, Cowger J, de By T, Nakatani T, Schueler S, et al. Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry. J Heart Lung Transplant. 2018;37:685–91.
Morgan JA, Brewer RJ, Nemeh HW, Gerlach B, Lanfear DE, Williams CT, et al. Stroke while on long-term left ventricular assist device support: incidence, outcome, and predictors. ASAIO J. 2014;60:284–9.
Flaherty ML, Kissela B, Khoury JC, Alwell K, Moomaw CJ, Woo D, et al. Carotid artery stenosis as a cause of stroke. Neuroepidemiology. 2013;40:36–41.
Templeton DL, John R, Painter P, Kelly AS, Dengel DR. Effects of the left ventricular assist device on the compliance and distensibility of the carotid artery. Heart Vessels. 2013;28:377–84.
Ambardekar AV, Hunter KS, Babu AN, Tuder RM, Dodson RB, Lindenfeld J. Changes in aortic wall structure, composition, and stiffness with continuous-flow left ventricular assist devices: a pilot study. Circ Heart Fail. 2015;8:944–52.
Saupe KW, Smith CA, Henderson KS, Dempsey JA. Diastolic time: an important determinant of regional arterial blood flow. Am J Physiol. 1995;269:H973–9.
Fukae K, Tominaga R, Tokunaga S, Kawachi Y, Imaizumi T, Yasui H. The effects of pulsatile and nonpulsatile systemic perfusion on renal sympathetic nerve activity in anesthetized dogs. J Thorac Cardiovasc Surg. 1996;111:478–84.
Gaer JA, Shaw AD, Wild R, Swift RI, Munsch CM, Smith PL, et al. Effect of cardiopulmonary bypass on gastrointestinal perfusion and function. Ann Thorac Surg. 1994;57:371–5.
Bartoli CR, Spence PA, Siess T, Raess DH, Koenig SC, Dowling RD. Nonphysiologic blood flow triggers endothelial and arterial remodeling in vivo: implications for novel left ventricular assist devices with a peripheral anastomosis. J Thorac Cardiovasc Surg. 2014;148:311–21.
Baeyens N, Schwartz MA. Biomechanics of vascular mechanosensation and remodeling. Mol Biol Cell. 2016;27:7–11.
Cornwell WK 3rd, Tarumi T, Stickford A, Lawley J, Roberts M, Parker R, et al. Restoration of pulsatile flow reduces sympathetic nerve activity among individuals with continuous-flow left ventricular assist devices. Circulation. 2015;132:2316–22.
Healy AH, McKellar SH, Drakos SG, Koliopoulou A, Stehlik J, Selzman CH. Physiologic effects of continuous-flow left ventricular assist devices. J Surg Res. 2016;202:363–71.
Mughal MM, Khan MK, DeMarco JK, Majid A, Shamoun F, Abela GS. Symptomatic and asymptomatic carotid artery plaque. Expert Rev Cardiovasc Ther. 2011;9:1315–30.
Cuadrado-Godia E, Ois A, Roquer J. Heart failure in acute ischemic stroke. Curr Cardiol Rev. 2010;6:202–13.
Prasad K. Pathophysiology and medical treatment of carotid artery stenosis. Int J Angiol. 2015;24:158–72.
Cushing K, Kushnir V. Gastrointestinal bleeding following LVAD placement from top to bottom. Dig Dis Sci. 2016;61:1440–7.
E. J. Stöhr and Barry J. McDonnell have received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Grant agreement No 705219.
Conflict of interest
Paolo Colombo has previously received grant funding from Abbott for unrelated work that in no way affected any aspect of this particular study. The remaining authors had no conflicts of interest whatsoever.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Kiyatkin, M.E., Zuver, A.M., Gaudig, A. et al. Carotid artery structure and hemodynamics and their association with adverse vascular events in left ventricular assist device patients. J Artif Organs (2021). https://doi.org/10.1007/s10047-020-01229-1
- Left ventricular assist device (LVAD)
- Heart mate II